Drugs

Pro-life movement has mixed reaction after Trump’s first year of second term #Catholic 
 
 Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News

Jan 20, 2026 / 14:37 pm (CNA).
Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.

Pro-life movement has mixed reaction after Trump’s first year of second term #Catholic Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News Jan 20, 2026 / 14:37 pm (CNA). Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.


Participants in a pro-life rally hold signs in front of the Lincoln Memorial in Washington, D.C., on June 24, 2023, at a rally marking the first anniversary of the Supreme Court's Dobbs decision that overturned Roe v. Wade. | Credit: Joseph Portolano/EWTN News

Jan 20, 2026 / 14:37 pm (CNA).

Members of the pro-life movement have mixed thoughts on the first year of President Donald Trump’s second term, noting many wins early into his presidency but a number of shortfalls as time has gone by.

Some wins include defunding Planned Parenthood, walking back some of President Joe Biden’s initiatives, and removing foreign aid funding for organizations that promote abortion. However, a lack of action on chemical abortions and weakened rhetoric surrounding taxpayer-funded abortions are causing concern.

A notable pro-life win was included in the tax overhaul bill signed by Trump in July, which cut off all Medicaid reimbursements for organizations that provide a large number of abortions, such as Planned Parenthood.

Amid funding cuts, nearly 70 Planned Parenthood affiliates shut down. The administration also initially cut off Title X family planning grants from the abortion giant, but those have resumed.

The president pardoned pro-life protesters convicted of violating the Freedom of Access to Clinic Entrances (FACE) Act and blocked foreign aid from supporting organizations that promote abortion. He rescinded several policies from the Biden administration, including one that paid Pentagon workers to travel for abortions. He also established strong conscience protections for pro-life doctors.

“Right out the gate, we saw some progress on the pro-life issue,” Kelsey Pritchard, a spokesperson for Susan B. Anthony Pro-Life America (SBA), told EWTN.

Yet, she cautioned: “We have also not seen progress in the one area that matters the most — and that’s on abortion drugs.”

Health Secretary Robert F. Kennedy Jr. launched a study into the safety of the abortion pill mifepristone in September 2025, but so far no action has been taken to curtail the drug. Rather, the Food and Drug Administration (FDA) went in the opposite direction, approving a generic version of mifepristone later that same month.

Pritchard said that move was “the opposite of what they should have done,” and referred to the generic mifepristone as “a new kill pill to increase the number of abortions that are done in this country.”

She said Kennedy’s promised study has “absolutely been moving too slow” and added that there is no confirmation it even began or is taking place. SBA called for FDA Commissioner Marty Makary to be fired following allegations he was “slow-walking the report for political reasons,” she said.

Trump has said abortion should be regulated by the states, but Pritchard warned “those [pro-life] laws can’t be in effect at all, really, when mail-order abortion happens with the abortion drugs.”

“They’re allowing [California Gov.] Gavin Newsom and [New York Gov.] Kathy Hochul and their blue state friends to completely nullify the pro-life laws in states like Texas and Florida,” she said.

Joseph Meaney, a senior ethicist at the National Catholic Bioethics Center, similarly said “the delay in the promised review of the rushed process in which mifepristone was approved as an abortion drug by the FDA has frustrated pro-lifers.”

“When the FDA approved a second generic version of mifepristone, … it highlighted the lack of progress in fighting the leading means of doing abortions in the [United States],” he said.

Trump also began to waver on taxpayer-funded abortions early in 2026, asking Republicans to be “flexible” on the Hyde Amendment amid negotiations on extending health care subsidies for the Affordable Care Act. Trump later unveiled “The Great Healthcare Plan” and said the White House intends to negotiate with Congress to ensure pro-life protections.

Pritchard called taxpayer-funded abortion “a very basic red line” and said it’s “concerning to see Republicans back away from something so basic.”

She warned Republicans to not take pro-life voters for granted in the upcoming midterms, saying “you’ll lose the elections and we won’t have the majority of Congress” without pro-life voters.

“You must remain the pro-life party or you will lose the midterms if you decide to bow to the pro-death Democrat agenda,” Pritchard said.

Meaney said there is “a widespread feeling that the second Trump administration has seemed to deprioritize issues important to the pro-life community,” adding he has “seen calls for pro-life groups to ‘flex their muscles’ and show that they cannot be taken for granted.”

However, he said the shortfalls “should not obscure the fact that the Trump administration has rolled back the Biden-era pro-abortion measures internationally and domestically.”

“It even achieved a temporary defunding of Planned Parenthood domestically in legislation,” he said. “The federal government no longer funds research on fetal tissues and defends the conscience rights of health care professionals and others robustly.”

Trump also signed an executive order that directed departments and agencies to boost access to and reduce the cost of in vitro fertilization (IVF). The Catholic Church opposes IVF, which results in the destruction of human embryos, ending human lives.

Read More
How federal and state abortion policies shifted in 2025 #Catholic 
 
 Fifty-one senators asked the FDA to rescind its approval of a generic version of the abortion drug mifepristone on Oct. 9, 2025. | Credit: Yta23/Shutterstock

Dec 30, 2025 / 07:00 am (CNA).
Abortion policy at the federal and state levels has continued to shift in the United States three and a half years since the Supreme Court overturned Roe v. Wade in its June 2022 Dobbs v. Jackson Women’s Health Organization decision.At the federal level, President Donald Trump’s administration and congressional Republicans made strides to pull back funding for organizations that advocate for abortion access and to reinstate conscience protections. Yet the administration also approved a generic abortion pill and failed to further regulate chemical abortion drugs.Some states adopted new restrictions on abortion, but others expanded policies to increase abortion access. In most states, changes to abortion policy were minimal, as many states already set their post-Dobbs abortion policies in the previous years.Federal: Trump administration shiftsAbortion policy at the federal level shifted shortly after Trump took office, with the administration reinstating many policies from Trump’s first term that had been abandoned for four years under President Joe Biden’s administration.Trump reinstated the Mexico City Policy during his first week in office, which requires foreign organizations to certify they will not perform, promote, or actively advocate for abortion to receive U.S. government funding. In June, the Centers for Medicare and Medicaid Services rescinded Biden-era guidelines that had required emergency rooms to perform abortions when a pregnant woman had a life-threatening emergency (like severe bleeding, ectopic pregnancy, or risk of organ failure) to stabilize her condition — even in states where abortion is otherwise banned.Other changes within federal departments and agencies included rescinding a Department of Defense policy that provided paid leave and travel expenses for abortion and a proposed rule change to end abortion at Veterans Affairs facilities.The Department of Health and Human Services has also withheld Title X family planning funds from Planned Parenthood. Trump also signed a government spending bill that withheld Medicaid reimbursements from Planned Parenthood. Federal tax money was not spent directly on abortion before those changes, but abortion providers did receive funds for other purposes.Nearly 70 Planned Parenthood abortion clinics shut down in 2025 amid funding cuts.Those closures came as the administration advanced changes affecting abortion medication. Although the administration announced it would review the abortion pill, the Food and Drug Administration approved a new generic version of the drug mifepristone. Bloomberg Law reported the review has been delayed, although officials deny it.The state-level results in 2025 have also been mixed, with a few states adding pro-life laws and others expanding access to abortion.In Texas, where nearly all abortions are illegal, lawmakers passed a bill that allows families to sue companies that manufacture or distribute chemical abortion pills. This comes as state laws related to chemical abortions often conflict, with states like New York enforcing “shield laws” that order courts to not cooperate with out-of-state lawsuits or criminal charges against abortionists within their states.Lawmakers in Wyoming passed a law overriding a veto from the governor that requires women to receive an ultrasound before they can obtain an abortion. However, the law was blocked by a court and is not in effect.There were two pro-life legal wins for states in 2025 as well.In November, the North Dakota Supreme Court ruled in favor of the state’s near-total abortion ban after it was temporarily blocked by a lower court. Under the law, unborn life is protected at every stage in pregnancy in most cases, but it remains legal in the first six weeks in cases of rape and incest and for the duration of pregnancy when the mother is at risk of death or serious physical harm.The U.S. Supreme Court ruled in June that a South Carolina policy to withhold Medicaid funding for Planned Parenthood could stay in place. This ruling also opened the door for other states to adopt similar policies moving forward.In at least 10 states, lawmakers enacted bills to provide more funding for pro-life pregnancy centers, which offer life-affirming alternatives to abortion for pregnant women.Alternatively, a handful of states in 2025 expanded their shield laws, which prevent courts from complying with out-of-state criminal or civil cases against abortionists. This includes new laws in California, Vermont, Massachusetts, and New York. Several states expanded these laws by allowing pharmacies to provide chemical abortion pills without listing the name of the doctor who prescribed them to prevent out-of-state legal action.About a dozen states expanded funding for abortion providers, such as California directing 0 million to Planned Parenthood to counteract federal defunding efforts. Maryland established a new program called the Public Health Abortion Grant Program, which offers abortion coverage through Affordable Care Act funds.New laws in Colorado and Washington require emergency rooms to provide abortions when the procedure is deemed “necessary.” A law adopted in Illinois requires public college campuses to provide the abortion pill at their pharmacies.Connecticut removed its parental notification policy regarding abortion, which means that minors are allowed to obtain abortions without the consent of their parents.As of December, 13 states prohibit most abortions, four states ban abortions after six weeks’ gestation, two have bans after 12 weeks, and one has a ban after 18 weeks. The other 30 states and the District of Columbia permit abortion up to the 22nd week or later. Nine of those states allow elective abortion through nine months until the moment of birth.

How federal and state abortion policies shifted in 2025 #Catholic Fifty-one senators asked the FDA to rescind its approval of a generic version of the abortion drug mifepristone on Oct. 9, 2025. | Credit: Yta23/Shutterstock Dec 30, 2025 / 07:00 am (CNA). Abortion policy at the federal and state levels has continued to shift in the United States three and a half years since the Supreme Court overturned Roe v. Wade in its June 2022 Dobbs v. Jackson Women’s Health Organization decision.At the federal level, President Donald Trump’s administration and congressional Republicans made strides to pull back funding for organizations that advocate for abortion access and to reinstate conscience protections. Yet the administration also approved a generic abortion pill and failed to further regulate chemical abortion drugs.Some states adopted new restrictions on abortion, but others expanded policies to increase abortion access. In most states, changes to abortion policy were minimal, as many states already set their post-Dobbs abortion policies in the previous years.Federal: Trump administration shiftsAbortion policy at the federal level shifted shortly after Trump took office, with the administration reinstating many policies from Trump’s first term that had been abandoned for four years under President Joe Biden’s administration.Trump reinstated the Mexico City Policy during his first week in office, which requires foreign organizations to certify they will not perform, promote, or actively advocate for abortion to receive U.S. government funding. In June, the Centers for Medicare and Medicaid Services rescinded Biden-era guidelines that had required emergency rooms to perform abortions when a pregnant woman had a life-threatening emergency (like severe bleeding, ectopic pregnancy, or risk of organ failure) to stabilize her condition — even in states where abortion is otherwise banned.Other changes within federal departments and agencies included rescinding a Department of Defense policy that provided paid leave and travel expenses for abortion and a proposed rule change to end abortion at Veterans Affairs facilities.The Department of Health and Human Services has also withheld Title X family planning funds from Planned Parenthood. Trump also signed a government spending bill that withheld Medicaid reimbursements from Planned Parenthood. Federal tax money was not spent directly on abortion before those changes, but abortion providers did receive funds for other purposes.Nearly 70 Planned Parenthood abortion clinics shut down in 2025 amid funding cuts.Those closures came as the administration advanced changes affecting abortion medication. Although the administration announced it would review the abortion pill, the Food and Drug Administration approved a new generic version of the drug mifepristone. Bloomberg Law reported the review has been delayed, although officials deny it.The state-level results in 2025 have also been mixed, with a few states adding pro-life laws and others expanding access to abortion.In Texas, where nearly all abortions are illegal, lawmakers passed a bill that allows families to sue companies that manufacture or distribute chemical abortion pills. This comes as state laws related to chemical abortions often conflict, with states like New York enforcing “shield laws” that order courts to not cooperate with out-of-state lawsuits or criminal charges against abortionists within their states.Lawmakers in Wyoming passed a law overriding a veto from the governor that requires women to receive an ultrasound before they can obtain an abortion. However, the law was blocked by a court and is not in effect.There were two pro-life legal wins for states in 2025 as well.In November, the North Dakota Supreme Court ruled in favor of the state’s near-total abortion ban after it was temporarily blocked by a lower court. Under the law, unborn life is protected at every stage in pregnancy in most cases, but it remains legal in the first six weeks in cases of rape and incest and for the duration of pregnancy when the mother is at risk of death or serious physical harm.The U.S. Supreme Court ruled in June that a South Carolina policy to withhold Medicaid funding for Planned Parenthood could stay in place. This ruling also opened the door for other states to adopt similar policies moving forward.In at least 10 states, lawmakers enacted bills to provide more funding for pro-life pregnancy centers, which offer life-affirming alternatives to abortion for pregnant women.Alternatively, a handful of states in 2025 expanded their shield laws, which prevent courts from complying with out-of-state criminal or civil cases against abortionists. This includes new laws in California, Vermont, Massachusetts, and New York. Several states expanded these laws by allowing pharmacies to provide chemical abortion pills without listing the name of the doctor who prescribed them to prevent out-of-state legal action.About a dozen states expanded funding for abortion providers, such as California directing $140 million to Planned Parenthood to counteract federal defunding efforts. Maryland established a new program called the Public Health Abortion Grant Program, which offers abortion coverage through Affordable Care Act funds.New laws in Colorado and Washington require emergency rooms to provide abortions when the procedure is deemed “necessary.” A law adopted in Illinois requires public college campuses to provide the abortion pill at their pharmacies.Connecticut removed its parental notification policy regarding abortion, which means that minors are allowed to obtain abortions without the consent of their parents.As of December, 13 states prohibit most abortions, four states ban abortions after six weeks’ gestation, two have bans after 12 weeks, and one has a ban after 18 weeks. The other 30 states and the District of Columbia permit abortion up to the 22nd week or later. Nine of those states allow elective abortion through nine months until the moment of birth.


Fifty-one senators asked the FDA to rescind its approval of a generic version of the abortion drug mifepristone on Oct. 9, 2025. | Credit: Yta23/Shutterstock

Dec 30, 2025 / 07:00 am (CNA).

Abortion policy at the federal and state levels has continued to shift in the United States three and a half years since the Supreme Court overturned Roe v. Wade in its June 2022 Dobbs v. Jackson Women’s Health Organization decision.

At the federal level, President Donald Trump’s administration and congressional Republicans made strides to pull back funding for organizations that advocate for abortion access and to reinstate conscience protections. Yet the administration also approved a generic abortion pill and failed to further regulate chemical abortion drugs.

Some states adopted new restrictions on abortion, but others expanded policies to increase abortion access. In most states, changes to abortion policy were minimal, as many states already set their post-Dobbs abortion policies in the previous years.

Federal: Trump administration shifts

Abortion policy at the federal level shifted shortly after Trump took office, with the administration reinstating many policies from Trump’s first term that had been abandoned for four years under President Joe Biden’s administration.

Trump reinstated the Mexico City Policy during his first week in office, which requires foreign organizations to certify they will not perform, promote, or actively advocate for abortion to receive U.S. government funding. In June, the Centers for Medicare and Medicaid Services rescinded Biden-era guidelines that had required emergency rooms to perform abortions when a pregnant woman had a life-threatening emergency (like severe bleeding, ectopic pregnancy, or risk of organ failure) to stabilize her condition — even in states where abortion is otherwise banned.

Other changes within federal departments and agencies included rescinding a Department of Defense policy that provided paid leave and travel expenses for abortion and a proposed rule change to end abortion at Veterans Affairs facilities.

The Department of Health and Human Services has also withheld Title X family planning funds from Planned Parenthood. Trump also signed a government spending bill that withheld Medicaid reimbursements from Planned Parenthood. Federal tax money was not spent directly on abortion before those changes, but abortion providers did receive funds for other purposes.

Nearly 70 Planned Parenthood abortion clinics shut down in 2025 amid funding cuts.

Those closures came as the administration advanced changes affecting abortion medication. Although the administration announced it would review the abortion pill, the Food and Drug Administration approved a new generic version of the drug mifepristone. Bloomberg Law reported the review has been delayed, although officials deny it.

The state-level results in 2025 have also been mixed, with a few states adding pro-life laws and others expanding access to abortion.

In Texas, where nearly all abortions are illegal, lawmakers passed a bill that allows families to sue companies that manufacture or distribute chemical abortion pills. This comes as state laws related to chemical abortions often conflict, with states like New York enforcing “shield laws” that order courts to not cooperate with out-of-state lawsuits or criminal charges against abortionists within their states.

Lawmakers in Wyoming passed a law overriding a veto from the governor that requires women to receive an ultrasound before they can obtain an abortion. However, the law was blocked by a court and is not in effect.

There were two pro-life legal wins for states in 2025 as well.

In November, the North Dakota Supreme Court ruled in favor of the state’s near-total abortion ban after it was temporarily blocked by a lower court. Under the law, unborn life is protected at every stage in pregnancy in most cases, but it remains legal in the first six weeks in cases of rape and incest and for the duration of pregnancy when the mother is at risk of death or serious physical harm.

The U.S. Supreme Court ruled in June that a South Carolina policy to withhold Medicaid funding for Planned Parenthood could stay in place. This ruling also opened the door for other states to adopt similar policies moving forward.

In at least 10 states, lawmakers enacted bills to provide more funding for pro-life pregnancy centers, which offer life-affirming alternatives to abortion for pregnant women.

Alternatively, a handful of states in 2025 expanded their shield laws, which prevent courts from complying with out-of-state criminal or civil cases against abortionists. This includes new laws in California, Vermont, Massachusetts, and New York. Several states expanded these laws by allowing pharmacies to provide chemical abortion pills without listing the name of the doctor who prescribed them to prevent out-of-state legal action.

About a dozen states expanded funding for abortion providers, such as California directing $140 million to Planned Parenthood to counteract federal defunding efforts. Maryland established a new program called the Public Health Abortion Grant Program, which offers abortion coverage through Affordable Care Act funds.

New laws in Colorado and Washington require emergency rooms to provide abortions when the procedure is deemed “necessary.” A law adopted in Illinois requires public college campuses to provide the abortion pill at their pharmacies.

Connecticut removed its parental notification policy regarding abortion, which means that minors are allowed to obtain abortions without the consent of their parents.

As of December, 13 states prohibit most abortions, four states ban abortions after six weeks’ gestation, two have bans after 12 weeks, and one has a ban after 18 weeks. The other 30 states and the District of Columbia permit abortion up to the 22nd week or later. Nine of those states allow elective abortion through nine months until the moment of birth.

Read More
2025 saw expanded access to physician-assisted suicide  #Catholic 
 
 Empty wheelchairs used during the Nov. 4, 2025, anti-assisted suicide event in Rome. / Credit: Courtesy of ProVita & Famiglia

Washington, D.C. Newsroom, Dec 28, 2025 / 07:00 am (CNA).
Despite opposition from advocacy groups and Catholic leaders, multiple states and countries advanced legislation in 2025 to expand access to physician-assisted suicide.Delaware Delaware Gov. Matt Meyer signed a bill in May legalizing physician-assisted suicide for terminally ill adults with a prognosis of six months or less to live. The law will go into effect on Jan. 1, 2026, allowing patients to self-administer lethal medication. After the bill was signed, several disability and patient advocacy groups filed a lawsuit in the U.S. District Court in Delaware on Dec. 8 alleging that the law discriminates against people with disabilities. Illinois The House passed a bill in May to legalize physician-assisted suicide in Illinois, and it stalled in the Senate during the regular session. After it was taken up during the fall veto session, senators passed it on Oct. 31. The bill, which allows doctors to give terminally ill patients life-ending drugs if they request them, was signed into law by Gov. JB Pritzker on Dec. 12. The law “ignores the very real failures in access to quality care that drive vulnerable people to despair,” according to the Catholic Conference of Illinois.Illinois joined states that permit the practice including California, Colorado, Delaware, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont, and Washington, as well as the District of Columbia.New York The New York State Assembly advanced an assisted suicide measure in May, which Cardinal Timothy Dolan called “a disaster waiting to happen.” Despite calls from Catholic bishops, the New York Legislature passed the “Medical Aid in Dying Act” in June.The legislation is expected to be signed by New York Gov. Kathy Hochul.ColoradoAssisted suicide has been legal in Colorado since 2016. In June 2025, a coalition of advocacy groups sued the state over its assisted suicide law, claiming the statute is unconstitutional for allegedly discriminating against those who suffer from disabilities. The suit was filed on June 30 in U.S. district court by organizations including Not Dead Yet and the Institute for Patients’ Rights. It calls Colorado’s assisted suicide regime “a deadly and discriminatory system that steers people with life-threatening disabilities away from necessary lifesaving and preserving mental health care.” FranceThe National Assembly approved a bill in May that would allow certain terminally ill adults to receive lethal medication. The bill passed with 305 votes in favor and 199 against. In a statement released after the vote, the French Bishops’ Conference expressed its “deep concern” over the so-called “right to assistance in dying.” United KingdomBritish lawmakers in the House of Commons passed a bill in June to legalize assisted suicide for terminally ill patients in England and Wales. In order to become law, the bill must pass the second chamber of Parliament, the unelected House of Lords. The Lords can amend legislation, but because the bill has the support of the Commons, it is likely to pass.Uruguay Legislators in Uruguay passed a bill in August to legalize euthanasia in the country. In October, Uruguay’s Parliament approved the “Dignified Death Bill,” making the bill law and allowing adults in the terminal stage of a disease to request euthanasia. Canada A Cardus Health report released in September found the legalization of medical assistance in dying (MAID) in Canada led to disproportionately high rates of premature deaths among vulnerable groups.MAID passed in 2012 with safeguards and provisions that the report said Canada has not upheld. It said: “Those who died from MAID were more likely to have been living with a disability than those who did not die from MAID, even though both groups had similar medical conditions and experienced diminished capability.”People suffering from mental illness are also dying by assisted suicide at disproportionate rates, the report said. 

2025 saw expanded access to physician-assisted suicide  #Catholic Empty wheelchairs used during the Nov. 4, 2025, anti-assisted suicide event in Rome. / Credit: Courtesy of ProVita & Famiglia Washington, D.C. Newsroom, Dec 28, 2025 / 07:00 am (CNA). Despite opposition from advocacy groups and Catholic leaders, multiple states and countries advanced legislation in 2025 to expand access to physician-assisted suicide.Delaware Delaware Gov. Matt Meyer signed a bill in May legalizing physician-assisted suicide for terminally ill adults with a prognosis of six months or less to live. The law will go into effect on Jan. 1, 2026, allowing patients to self-administer lethal medication. After the bill was signed, several disability and patient advocacy groups filed a lawsuit in the U.S. District Court in Delaware on Dec. 8 alleging that the law discriminates against people with disabilities. Illinois The House passed a bill in May to legalize physician-assisted suicide in Illinois, and it stalled in the Senate during the regular session. After it was taken up during the fall veto session, senators passed it on Oct. 31. The bill, which allows doctors to give terminally ill patients life-ending drugs if they request them, was signed into law by Gov. JB Pritzker on Dec. 12. The law “ignores the very real failures in access to quality care that drive vulnerable people to despair,” according to the Catholic Conference of Illinois.Illinois joined states that permit the practice including California, Colorado, Delaware, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont, and Washington, as well as the District of Columbia.New York The New York State Assembly advanced an assisted suicide measure in May, which Cardinal Timothy Dolan called “a disaster waiting to happen.” Despite calls from Catholic bishops, the New York Legislature passed the “Medical Aid in Dying Act” in June.The legislation is expected to be signed by New York Gov. Kathy Hochul.ColoradoAssisted suicide has been legal in Colorado since 2016. In June 2025, a coalition of advocacy groups sued the state over its assisted suicide law, claiming the statute is unconstitutional for allegedly discriminating against those who suffer from disabilities. The suit was filed on June 30 in U.S. district court by organizations including Not Dead Yet and the Institute for Patients’ Rights. It calls Colorado’s assisted suicide regime “a deadly and discriminatory system that steers people with life-threatening disabilities away from necessary lifesaving and preserving mental health care.” FranceThe National Assembly approved a bill in May that would allow certain terminally ill adults to receive lethal medication. The bill passed with 305 votes in favor and 199 against. In a statement released after the vote, the French Bishops’ Conference expressed its “deep concern” over the so-called “right to assistance in dying.” United KingdomBritish lawmakers in the House of Commons passed a bill in June to legalize assisted suicide for terminally ill patients in England and Wales. In order to become law, the bill must pass the second chamber of Parliament, the unelected House of Lords. The Lords can amend legislation, but because the bill has the support of the Commons, it is likely to pass.Uruguay Legislators in Uruguay passed a bill in August to legalize euthanasia in the country. In October, Uruguay’s Parliament approved the “Dignified Death Bill,” making the bill law and allowing adults in the terminal stage of a disease to request euthanasia. Canada A Cardus Health report released in September found the legalization of medical assistance in dying (MAID) in Canada led to disproportionately high rates of premature deaths among vulnerable groups.MAID passed in 2012 with safeguards and provisions that the report said Canada has not upheld. It said: “Those who died from MAID were more likely to have been living with a disability than those who did not die from MAID, even though both groups had similar medical conditions and experienced diminished capability.”People suffering from mental illness are also dying by assisted suicide at disproportionate rates, the report said. 


Empty wheelchairs used during the Nov. 4, 2025, anti-assisted suicide event in Rome. / Credit: Courtesy of ProVita & Famiglia

Washington, D.C. Newsroom, Dec 28, 2025 / 07:00 am (CNA).

Despite opposition from advocacy groups and Catholic leaders, multiple states and countries advanced legislation in 2025 to expand access to physician-assisted suicide.

Delaware 

Delaware Gov. Matt Meyer signed a bill in May legalizing physician-assisted suicide for terminally ill adults with a prognosis of six months or less to live. The law will go into effect on Jan. 1, 2026, allowing patients to self-administer lethal medication. 

After the bill was signed, several disability and patient advocacy groups filed a lawsuit in the U.S. District Court in Delaware on Dec. 8 alleging that the law discriminates against people with disabilities. 

Illinois 

The House passed a bill in May to legalize physician-assisted suicide in Illinois, and it stalled in the Senate during the regular session. After it was taken up during the fall veto session, senators passed it on Oct. 31. 

The bill, which allows doctors to give terminally ill patients life-ending drugs if they request them, was signed into law by Gov. JB Pritzker on Dec. 12. The law “ignores the very real failures in access to quality care that drive vulnerable people to despair,” according to the Catholic Conference of Illinois.

Illinois joined states that permit the practice including California, Colorado, Delaware, Hawaii, Maine, Montana, New Jersey, New Mexico, Oregon, Vermont, and Washington, as well as the District of Columbia.

New York 

The New York State Assembly advanced an assisted suicide measure in May, which Cardinal Timothy Dolan called “a disaster waiting to happen.” Despite calls from Catholic bishops, the New York Legislature passed the “Medical Aid in Dying Act” in June.

The legislation is expected to be signed by New York Gov. Kathy Hochul.

Colorado

Assisted suicide has been legal in Colorado since 2016. In June 2025, a coalition of advocacy groups sued the state over its assisted suicide law, claiming the statute is unconstitutional for allegedly discriminating against those who suffer from disabilities. 

The suit was filed on June 30 in U.S. district court by organizations including Not Dead Yet and the Institute for Patients’ Rights. It calls Colorado’s assisted suicide regime “a deadly and discriminatory system that steers people with life-threatening disabilities away from necessary lifesaving and preserving mental health care.” 

France

The National Assembly approved a bill in May that would allow certain terminally ill adults to receive lethal medication. The bill passed with 305 votes in favor and 199 against. 

In a statement released after the vote, the French Bishops’ Conference expressed its “deep concern” over the so-called “right to assistance in dying.” 

United Kingdom

British lawmakers in the House of Commons passed a bill in June to legalize assisted suicide for terminally ill patients in England and Wales. 

In order to become law, the bill must pass the second chamber of Parliament, the unelected House of Lords. The Lords can amend legislation, but because the bill has the support of the Commons, it is likely to pass.

Uruguay 

Legislators in Uruguay passed a bill in August to legalize euthanasia in the country. In October, Uruguay’s Parliament approved the “Dignified Death Bill,” making the bill law and allowing adults in the terminal stage of a disease to request euthanasia. 

Canada 

A Cardus Health report released in September found the legalization of medical assistance in dying (MAID) in Canada led to disproportionately high rates of premature deaths among vulnerable groups.

MAID passed in 2012 with safeguards and provisions that the report said Canada has not upheld. It said: “Those who died from MAID were more likely to have been living with a disability than those who did not die from MAID, even though both groups had similar medical conditions and experienced diminished capability.”

People suffering from mental illness are also dying by assisted suicide at disproportionate rates, the report said. 

Read More
Trump eases marijuana regulations amid industry backing, Catholic concerns #Catholic 
 
 President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA).
President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. “Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 

Trump eases marijuana regulations amid industry backing, Catholic concerns #Catholic President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA). President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. “Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 


President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA).

President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.

Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.

Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.

Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.

Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.

In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”

“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.

“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”

Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. 

“Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.

“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.

Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. 

The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.

In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.

The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 

Read More
Advocates push EPA to include abortion drugs on list of drinking water contaminants #Catholic 
 
 null / Credit: Carl DMaster/Shutterstock

Washington, D.C. Newsroom, Dec 18, 2025 / 16:48 pm (CNA).
Here is a roundup of recent pro-life and abortion-related news:Advocates push for EPA to include chemicals from abortion drugs on list of drinking water contaminantsStudents for Life of America (SFLA) is calling on the Environmental Protection Agency (EPA) to add the abortion drug mifepristone to a list of drinking water contaminants tracked by public utilities. “It’s a problem only the EPA can fully investigate,” SFLA reported.In two letters over the last several sessions of Congress, legislators have called on the EPA to find out the extent of the damage of abortion drug water pollution. Multiple pro-life and pro-family organizations joined together to ask the EPA to look into the chemicals.“The EPA has the regulatory authority and humane responsibility to determine the extent of abortion water pollution, caused by the reckless and negligent policies pushed by past administrations through the FDA [Food and Drug Administration],” said Kristan Hawkins, president of SFLA.“Take the word ‘abortion’ out of it and ask, should chemically tainted blood and placenta tissue, along with human remains, be flushed by the tons into America’s waterways? And since the federal government set that up, shouldn’t we know what’s in our water?” she said.Ireland votes not to restore bill that would remove three-day waiting period for abortionsThe Dáil, the lower house and main chamber of the Irish Parliament, has voted against restoring an abortion bill that would have decriminalized abortion up until birth and removed the three-day waiting period for an abortion. The legislation previously passed the second stage in the Dáil, but Parliament members decided in a 73 to 71 vote to reject it.The legislation would have allowed abortion on request before “viability” and on grounds of a fatal fetal abnormality that would likely lead to the death of the baby before birth or within a year of birth. Missouri senator launches new pro-life initiativeU.S. Sen. Josh Hawley of Missouri and his wife, Erin Hawley, announced they are launching a new effort to advocate for families and the unborn called the Love Life Initiative. The effort is intended to “remind Americans that life is sacred, life is good, and life is worth protecting.”The Love Life Initiative was “born out of the recognition that pro-life victories in the courtroom is not enough,” according to the initiative’s website. At the time of the Dobbs ruling, 49% of Americans identified as pro-choice and 46% as pro-life, Love Life reported. Today, 53% identify as pro-choice and only 39% identify as pro-life. The initiative plans to work to reverse this trend through “thoughtful, far-reaching advertising campaigns that promote the sanctity of life, advance referendums that protect life, and identify and defeat harmful proposals in statehouses across the nation.”

Advocates push EPA to include abortion drugs on list of drinking water contaminants #Catholic null / Credit: Carl DMaster/Shutterstock Washington, D.C. Newsroom, Dec 18, 2025 / 16:48 pm (CNA). Here is a roundup of recent pro-life and abortion-related news:Advocates push for EPA to include chemicals from abortion drugs on list of drinking water contaminantsStudents for Life of America (SFLA) is calling on the Environmental Protection Agency (EPA) to add the abortion drug mifepristone to a list of drinking water contaminants tracked by public utilities. “It’s a problem only the EPA can fully investigate,” SFLA reported.In two letters over the last several sessions of Congress, legislators have called on the EPA to find out the extent of the damage of abortion drug water pollution. Multiple pro-life and pro-family organizations joined together to ask the EPA to look into the chemicals.“The EPA has the regulatory authority and humane responsibility to determine the extent of abortion water pollution, caused by the reckless and negligent policies pushed by past administrations through the FDA [Food and Drug Administration],” said Kristan Hawkins, president of SFLA.“Take the word ‘abortion’ out of it and ask, should chemically tainted blood and placenta tissue, along with human remains, be flushed by the tons into America’s waterways? And since the federal government set that up, shouldn’t we know what’s in our water?” she said.Ireland votes not to restore bill that would remove three-day waiting period for abortionsThe Dáil, the lower house and main chamber of the Irish Parliament, has voted against restoring an abortion bill that would have decriminalized abortion up until birth and removed the three-day waiting period for an abortion. The legislation previously passed the second stage in the Dáil, but Parliament members decided in a 73 to 71 vote to reject it.The legislation would have allowed abortion on request before “viability” and on grounds of a fatal fetal abnormality that would likely lead to the death of the baby before birth or within a year of birth. Missouri senator launches new pro-life initiativeU.S. Sen. Josh Hawley of Missouri and his wife, Erin Hawley, announced they are launching a new effort to advocate for families and the unborn called the Love Life Initiative. The effort is intended to “remind Americans that life is sacred, life is good, and life is worth protecting.”The Love Life Initiative was “born out of the recognition that pro-life victories in the courtroom is not enough,” according to the initiative’s website. At the time of the Dobbs ruling, 49% of Americans identified as pro-choice and 46% as pro-life, Love Life reported. Today, 53% identify as pro-choice and only 39% identify as pro-life. The initiative plans to work to reverse this trend through “thoughtful, far-reaching advertising campaigns that promote the sanctity of life, advance referendums that protect life, and identify and defeat harmful proposals in statehouses across the nation.”


null / Credit: Carl DMaster/Shutterstock

Washington, D.C. Newsroom, Dec 18, 2025 / 16:48 pm (CNA).

Here is a roundup of recent pro-life and abortion-related news:

Advocates push for EPA to include chemicals from abortion drugs on list of drinking water contaminants

Students for Life of America (SFLA) is calling on the Environmental Protection Agency (EPA) to add the abortion drug mifepristone to a list of drinking water contaminants tracked by public utilities. “It’s a problem only the EPA can fully investigate,” SFLA reported.

In two letters over the last several sessions of Congress, legislators have called on the EPA to find out the extent of the damage of abortion drug water pollution. Multiple pro-life and pro-family organizations joined together to ask the EPA to look into the chemicals.

“The EPA has the regulatory authority and humane responsibility to determine the extent of abortion water pollution, caused by the reckless and negligent policies pushed by past administrations through the FDA [Food and Drug Administration],” said Kristan Hawkins, president of SFLA.

“Take the word ‘abortion’ out of it and ask, should chemically tainted blood and placenta tissue, along with human remains, be flushed by the tons into America’s waterways? And since the federal government set that up, shouldn’t we know what’s in our water?” she said.

Ireland votes not to restore bill that would remove three-day waiting period for abortions

The Dáil, the lower house and main chamber of the Irish Parliament, has voted against restoring an abortion bill that would have decriminalized abortion up until birth and removed the three-day waiting period for an abortion. The legislation previously passed the second stage in the Dáil, but Parliament members decided in a 73 to 71 vote to reject it.

The legislation would have allowed abortion on request before “viability” and on grounds of a fatal fetal abnormality that would likely lead to the death of the baby before birth or within a year of birth. 

Missouri senator launches new pro-life initiative

U.S. Sen. Josh Hawley of Missouri and his wife, Erin Hawley, announced they are launching a new effort to advocate for families and the unborn called the Love Life Initiative. The effort is intended to “remind Americans that life is sacred, life is good, and life is worth protecting.”

The Love Life Initiative was “born out of the recognition that pro-life victories in the courtroom is not enough,” according to the initiative’s website. 

At the time of the Dobbs ruling, 49% of Americans identified as pro-choice and 46% as pro-life, Love Life reported. Today, 53% identify as pro-choice and only 39% identify as pro-life. The initiative plans to work to reverse this trend through “thoughtful, far-reaching advertising campaigns that promote the sanctity of life, advance referendums that protect life, and identify and defeat harmful proposals in statehouses across the nation.”

Read More
HHS announces actions to restrict ‘sex-rejecting procedures’ on minors #Catholic 
 
 President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA).
The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”

HHS announces actions to restrict ‘sex-rejecting procedures’ on minors #Catholic President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA). The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”


President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA).

The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.

Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.

This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.

It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.

HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.

The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”

Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.

HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”

“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” 

The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.

In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”

HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.

Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”

“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”

Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”

“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”

“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”

In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”

“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”

Read More